Complete financial analysis of Biomotion Sciences Warrant (SLXNW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biomotion Sciences Warrant, a leading company in the Biotechnology industry within the Healthcare sector.
- Viva Leisure Limited (VVA.AX) Income Statement Analysis – Financial Results
- Adamas One Corp. (JEWL) Income Statement Analysis – Financial Results
- Indian Overseas Bank (IOB.BO) Income Statement Analysis – Financial Results
- Thai Vegetable Oil Public Company Limited (TVO.BK) Income Statement Analysis – Financial Results
- China Chemical Corp. (CHCC) Income Statement Analysis – Financial Results
Biomotion Sciences Warrant (SLXNW)
About Biomotion Sciences Warrant
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Source: https://incomestatements.info
Category: Stock Reports